40 research outputs found

    third caesarean section in patient with myasthenia gravis

    Get PDF
    Abstract Myasthenia gravis (MG) is an autoimmune neuromuscular disease, characterised by muscle weakness and fatigability of the voluntary muscles, it affects young women in the second and third decade of life. We report a case of 30 years old multigravida woman with myasthenia gravis submitted to third iterative caesarean section with no adverse neonatal and maternal outcome. The course myathenia is highly variable and unpredictable during gestation and can change in subsequent pregnancies. Delivery specially, through caesarean section is very stressful and may cause severe myasthenic crisis. Although pregnancy and delivery represent particular events, that require more attention in these patients, they are not associated, in most cases, with higher risks of complications compared to normal pregnancy, delivery and postpartum period. According our experiences, in the management of myasthenic pregnant woman is necessary cooperation in a multidisciplinary team between obstetricians, neurologist, anaesthetist, and neonatologist for ensure an optimum outcome

    I trattati maggiori dell’amore di Dio

    No full text
    volume III e conclusivo della monumentale serie: BEATO PAOLO GIUSTINIANI, Trattati, lettere e frammenti dai manoscritti originali dell’Archivio dei Camaldolesi di Monte Corona nell’eremo di Frascati, iniziata nel 1967

    Tecniche invasive di diagnosi prenatale

    No full text

    Synthesis and preliminary structure-activity relationship study of 2-aryl-2H-pyrazolo[4,3-c]quinolin-3-ones as potential checkpoint kinase 1 (Chk1) inhibitors

    Get PDF
    The serine-threonine checkpoint kinase 1 (Chk1) plays a critical role in the cell cycle arrest in response to DNA damage. In the last decade, Chk1 inhibitors have emerged as a novel therapeutic strategy to potentiate the anti-tumour efficacy of cytotoxic chemotherapeutic agents. In the search for new Chk1 inhibitors, a congeneric series of 2-aryl-2 H-pyrazolo[4,3-c]quinolin-3-one (PQ) was evaluated by in-vitro and in-silico approaches for the first time. A total of 30 PQ structures were synthesised in good to excellent yields using conventional or microwave heating, highlighting that 14 of them are new chemical entities. Noteworthy, in this preliminary study two compounds 4e 2 and 4h 2 have shown a modest but significant reduction in the basal activity of the Chk1 kinase. Starting from these preliminary results, we have designed the second generation of analogous in this class and further studies are in progress in our laboratories.Fil: Malvacio, Ivana. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico Conicet - CĂłrdoba. Instituto de Investigaciones en FĂ­sico-quĂ­mica de CĂłrdoba. Universidad Nacional de CĂłrdoba. Facultad de Ciencias QuĂ­micas. Instituto de Investigaciones en FĂ­sico-quĂ­mica de CĂłrdoba; ArgentinaFil: Cuzzolin, Alberto. UniversitĂ  di Padova; ItaliaFil: Sturlese, Mattia. UniversitĂ  di Padova; ItaliaFil: Vera, Domingo Mariano Adolfo. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico Conicet - Mar del Plata. Instituto de Investigaciones en Biodiversidad y BiotecnologĂ­a; ArgentinaFil: Moyano, Elizabeth Laura. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico Conicet - CĂłrdoba. Instituto de Investigaciones en FĂ­sico-quĂ­mica de CĂłrdoba. Universidad Nacional de CĂłrdoba. Facultad de Ciencias QuĂ­micas. Instituto de Investigaciones en FĂ­sico-quĂ­mica de CĂłrdoba; ArgentinaFil: Moro, Stefano. UniversitĂ  di Padova; Itali
    corecore